926660-07-3 Usage
Uses
Used in Organic Synthesis:
(S)-N-((S)-1-(tert-butyldimethylsilyloxy)but-3-en-2-yl)-2-methylpropane-2-sulfinamide is used as a building block in organic synthesis for the preparation of complex molecules with specific stereochemistry. Its unique structure allows for the creation of a variety of compounds with potential applications in various fields.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (S)-N-((S)-1-(tert-butyldimethylsilyloxy)but-3-en-2-yl)-2-methylpropane-2-sulfinamide is used as a key intermediate in the synthesis of drugs with chiral centers. Its versatile chemical structure enables the development of new pharmaceutical compounds with improved efficacy and selectivity.
Used in Agrochemical Industry:
(S)-N-((S)-1-(tert-butyldimethylsilyloxy)but-3-en-2-yl)-2-methylpropane-2-sulfinamide may also find applications in the agrochemical industry as a precursor for the synthesis of chiral pesticides or other agrochemicals. Its unique structure can contribute to the development of more effective and selective agrochemical products.
Further research and development are necessary to fully explore the potential of (S)-N-((S)-1-(tert-butyldimethylsilyloxy)but-3-en-2-yl)-2-methylpropane-2-sulfinamide in these and other fields, as its versatile chemical structure offers numerous possibilities for innovative applications.
Check Digit Verification of cas no
The CAS Registry Mumber 926660-07-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,6,6 and 0 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 926660-07:
(8*9)+(7*2)+(6*6)+(5*6)+(4*6)+(3*0)+(2*0)+(1*7)=183
183 % 10 = 3
So 926660-07-3 is a valid CAS Registry Number.
926660-07-3Relevant academic research and scientific papers
Synthesis of potent bicyclic bisarylimidazole c-Jun N-terminal kinase inhibitors by catalytic C-H bond activation
Rech, Jason C.,Yato, Michihisa,Duckett, Derek,Ember, Brian,LoGrasso, Philip V.,Bergman, Robert G.,Ellman, Jonathan A.
, p. 490 - 491 (2007/10/03)
The efficient preparation of the privileged bicyclic bisarylimidazole kinase inhibitor scaffold was accomplished using rhodium-catalyzed C-H activation and intramolecular alkylation. The key C-H activation/alkylation step represents one of the first evalu
